Question 1

What is Acer Therapeutics' focus?

Accepted Answer

Acer Therapeutics is committed to developing therapies for patients with serious, rare, and life-threatening diseases. The company is focused on supporting patients and families who need it most.

Question 2

What are some of Acer's key product pipeline candidates?

Accepted Answer

Acer's product pipeline includes investigational therapies for Maple Syrup Urine Disease (MSUD) and Vascular Ehlers-Danlos Syndrome (VEDS). The company's lead candidate is Olpruva, an investigational therapy.

Question 3

How can patients and physicians access Acer's products?

Accepted Answer

Acer offers an expanded access program to provide investigational therapies to eligible patients with serious or life-threatening diseases who lack therapeutic options. Patients and physicians can contact the company to learn more about this program.

Question 4

Where can investors find information about Acer Therapeutics?

Accepted Answer

Investors can find information about Acer Therapeutics on the company's investor relations page, including press releases, SEC filings, analyst coverage, and corporate governance details.

Question 5

How can I stay updated on Acer Therapeutics' progress?

Accepted Answer

Individuals can sign up to receive updates from Acer Therapeutics by providing their name, email address, and other relevant information on the company's website.

Voyager DB

Contact Research

Chrome Extension

Acer Therapeutics

Company Overview

Company Name

Address

Website

Phone

Approx. Annual Revenue

Employees

Established

About Acer Therapeutics

More Companies in Massachusetts

Frequently Asked Questions about Acer Therapeutics

What is Acer Therapeutics' focus?

What are some of Acer's key product pipeline candidates?

How can patients and physicians access Acer's products?

Where can investors find information about Acer Therapeutics?

How can I stay updated on Acer Therapeutics' progress?

Categories

Technologies Used

Social Profiles

Key Decision Makers